0000950123-18-004349.txt : 20180508
0000950123-18-004349.hdr.sgml : 20180508
20180508172330
ACCESSION NUMBER: 0000950123-18-004349
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180331
FILED AS OF DATE: 20180508
DATE AS OF CHANGE: 20180508
EFFECTIVENESS DATE: 20180508
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BB BIOTECH AG
CENTRAL INDEX KEY: 0000924223
IRS NUMBER: 000000000
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-06964
FILM NUMBER: 18815872
BUSINESS ADDRESS:
STREET 1: SCHWERTSTRASSE 6
CITY: SCHAFFHAUSEN
STATE: V8
ZIP: 8200
BUSINESS PHONE: 411724 59 59
MAIL ADDRESS:
STREET 1: SCHWERTSTRASSE 6
CITY: SCHAFFHAUSEN
STATE: V8
ZIP: 8200
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0000924223
XXXXXXXX
03-31-2018
03-31-2018
BB BIOTECH AG
SCHWERTSTRASSE 6
SCHAFFHAUSEN
V8
8200
13F HOLDINGS REPORT
028-06964
N
Ivo Betschart
SIGNING AUTHORITY
41 (44) 267 67 00
/s/ Ivo Betschart
Schaffhausen
V8
05-07-2018
4
30
3618344
false
1
28-11193
Biotech Focus N V
2
28-11191
Biotech Invest N V
3
28-11189
Biotech Target N V
4
28-11194
Biotech Growth N V
INFORMATION TABLE
2
form13fInfoTable.xml
INFORMATION TABLE FOR FORM 13F
Achillion Pharmaceuticals Inc.
COM
00448Q201
4746
1279340
SH
DFND
3
1279340
0
0
Agios Pharmaceuticals Inc.
COM
00847X104
207333
2535253
SH
DFND
3
2535253
0
0
Akcea Therapeutics, Inc.
COM
00972L107
61197
2389571
SH
DFND
3
2389571
0
0
Alder Biopharmaceuticals Inc.
COM
014339105
28778
2266008
SH
DFND
3
2266008
0
0
Alexion Pharmaceuticals Inc.
COM
015351109
155423
1394428
SH
DFND
2
1394428
0
0
Alnylam Pharmaceuticals Inc.
COM
02043Q107
120450
1011338
SH
DFND
3
1011338
0
0
Argenx SE
SPONSORED ADR
04016X101
31920
396819
SH
DFND
3
396819
0
0
AveXis, Inc.
COM
05366U100
49778
402800
SH
DFND
3
402800
0
0
Celgene Corp
COM
151020104
296561
3324298
SH
DFND
2
3324298
0
0
Cidara Therapeutics Inc.
COM
171757107
9181
2295272
SH
DFND
3
2295272
0
0
Esperion Therapeutics Inc.
COM
29664W105
174530
2412964
SH
DFND
3
2412964
0
0
Five Prime Therapeutics Inc.
COM
33830X104
16793
977500
SH
DFND
3
977500
0
0
Gilead Sciences Inc.
COM
375558103
201638
2674596
SH
DFND
1
2674596
0
0
Halozyme Therapeutics Inc.
COM
40637H109
166909
8520137
SH
DFND
3
8520137
0
0
Incyte Corp.
COM
45337C102
308181
3698322
SH
DFND
3
3698322
0
0
Intercept Pharmaceuticals Inc.
COM
45845P108
33573
545719
SH
DFND
3
545719
0
0
Intra-Cellular Therapies Inc.
COM
46116X101
46310
2200000
SH
DFND
3
2200000
0
0
Ionis Pharmaceuticals Inc.
COM
462222100
375400
8516334
SH
DFND
3
8516334
0
0
MacroGenics Inc.
COM
556099109
65426
2600412
SH
DFND
3
2600412
0
0
Myovant Sciences Ltd.
COM
G637AM102
74613
3507882
SH
DFND
3
3507882
0
0
Neurocrine Biosciences Inc.
COM
64125C109
282190
3402753
SH
DFND
3
3402753
0
0
Novavax Inc.
COM
670002104
17493
8330000
SH
DFND
3
8330000
0
0
Prothena Corp. PLC
SHS
G72800108
14684
400000
SH
DFND
3
400000
0
0
Radius Health Inc.
COM NEW
750469207
210386
5853799
SH
DFND
4
5853799
0
0
Regeneron Pharmaceuticals Inc.
COM
75886F107
96421
280000
SH
DFND
2
280000
0
0
Sage Therapeutics Inc.
COM
78667J108
161463
1002439
SH
DFND
3
1002439
0
0
Tesaro Inc.
COM
881569107
93124
1629743
SH
DFND
3
1629743
0
0
Vertex Pharmaceuticals Inc.
COM
92532F100
240468
1475445
SH
DFND
3
1475445
0
0
Voyager Therapeutics Inc.
COM
92915B106
37442
1992641
SH
DFND
3
1992641
0
0
Wave Life Sciences Ltd.
SHS
Y95308105
35933
896096
SH
DFND
3
896096
0
0